Skip Navigation
  Print Page

Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB)

Skip sharing on social media links
Share this:
Skip Internal Navigation ​​

Overview

The OPPTB, formerly the Obstetric and Pediatric Pharmacology (OPP) Branch, promotes basic, translational, and clinical research to improve the safety and efficacy of pharmaceuticals and to ensure centralization and coordination of research, clinical trials, and drug development activities for obstetric and pediatric populations.

The Branch is responsible for developing and supporting a comprehensive national effort to increase the knowledge base for understanding how to appropriately treat disease during pregnancy, infancy, childhood, and adolescence using therapeutic approaches including medications that are appropriately tested within their target populations.

Implementation of the Best Pharmaceuticals for Children Act (BPCA) activities at the NICHD is among the major activities for the Branch.

Read more about Branch activities in the OPP Branch Report to the NACHHD Council, 2008 (PDF – 303 KB).

​​​​​​​​​​​​​​​​​​​​​​​​​ ​​​​​​​​​​​​​​​​​​​​​​​​
Last Updated Date: 10/30/2013
Last Reviewed Date: 10/30/2013

Contact Information

Name: Dr Anne Zajicek
Branch Chief
Obstetric and Pediatric Pharmacology and Therapeutics Branch
Phone: 301-435-6865
Fax: 301-480-2897
Email: zajiceka@mail.nih.gov

Staff Directory

Related A-Z Topics

Related FOAs

NICHD News and Spotlights

Related Conferences

Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology